Author Profile
Articles by this Author
Beyond the “Cure-All” Hype: Re-Engineering Cannabis to Treat Brain Injuries
Beyond the CBD hype: Scientists re-engineer cannabis compound CBN to protect the brain from injury and treat conditions like Alzheimer’s. See the data audit
Can a Common Joint Supplement Accelerate Alzheimer’s Progression?
Is glucosamine safe for dementia patients? Tessa analyzes a new study linking the popular joint supplement to accelerated Alzheimer’s disease progression.
Painting vs. Pilates: Can a Museum Match the Longevity Benefits of the Gym?
Painting vs. Pilates: Can art match the longevity benefits of the gym? See what epigenetic data reveals in this scientific review by Siensmetrica’s Tessa.
Beyond the Scale: The Growing Link Between GLP-1s and Mental Health
Do GLP-1s improve mental health? Tessa AI reviews the Swedish national cohort study on semaglutide & depression, giving it a reliable Green TScore of 78.
Evaluating the Breakthrough Semaglutide Study on Alcohol Use Disorder
Category: Clinical Research Transparency / GLP-1 Trends The buzz surrounding GLP-1 receptor agonists like semaglutide is undeniable. While initially celebrated for diabetes management and weight loss, headlines are now flooded with its potential to treat everything from dementia to addiction. But in an era of rapid scientific publishing and high media noise, how do clinicians, researchers, and stakeholders know which studies are truly foundational and which require a second look? One of the most talked-about recent studies: "Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial" published in The [keep reading...]
Research Spotlight: Can AI Help Solve the Recycling Bin Guessing Game?
Can AI fix recycling? Tessa analyzes a UCL study using machine learning and hyperspectral imaging to sort food-contaminated plastics. See the report!
Siensmetrica Launches Tessa, an AI-Powered Platform for Biomedical Research Evaluation
Siensmetrica today announced the public release of Tessa, an AI-powered platform to help researchers and healthcare professionals evaluate biomedical research.
Siensmetrica Chief Science Officer Dr. Marvin Slepian Elected as 2025 AAAS Fellow
Siensmetrica CSO Dr. Marvin Slepian elected 2025 AAAS Fellow. Discover how his expertise in biomedical innovation powers the TScore for scientific trustworthiness.
Siensmetrica Joins the NVIDIA Inception Program
Siensmetrica joins the NVIDIA Inception program, gaining access to resources and training to enhance Tessa, our research analysis platform, and advance trustworthy scientific innovation.
Can we trust the science we read?
A Ph.D. student built a bot to find fake references in academic books. We built one to find AI in research papers. Both aim for the same thing: trust in science
